Split History
ETFs Holding ATRC »    ATRC Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AtriCure is engaged in surgical treatments for atrial fibrillation and left atrial appendage management. Co. has two product lines for cardiac tissue ablation, comprising Radio Frequency Ablation Devices and cryoICE Cryoablation System; and a product line for left atrial appendage management, AtriClip System. Co. also sells enabling technologies including its Lumitip™ dissectors and the Estech line of reusable cardiac surgery instruments. The Lumitip dissector is used to separate tissues to provide access to main anatomical structures that are targeted for ablation. The Estech cardiac surgery instruments are used during surgical procedures for repair or replacement of certain heart valves. According to our ATRC split history records, AtriCure has had 1 split.
ATRC split history picture
AtriCure (ATRC) has 1 split in our ATRC split history database. The split for ATRC took place on February 01, 1996. This was a 1 for 10 reverse split, meaning for each 10 shares of ATRC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as AtriCure conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ATRC split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AtriCure shares, starting with a $10,000 purchase of ATRC, presented on a split-history-adjusted basis factoring in the complete ATRC split history. ATRC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/26/2007
End date: 02/24/2017
Start price/share: $10.95
End price/share: $17.65
Dividends collected/share: $0.00
Total return: 61.19%
Average Annual Total Return: 4.89%
Starting investment: $10,000.00
Ending investment: $16,121.21
Years: 10.00
Date Ratio
02/01/19961 for 10
ATRC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ATRI Split History
AVXL Split History
AZN Split History
BAX Split History
BCR Split History
BDMS Split History
BDX Split History
BGMD Split History
BIO Split History
BIOC Split History

TearLab Corporation (TEAR)
Pareteum Corporation (TEUM)
MoSys, Inc. (MOSY)
Catalyst Biosciences, Inc. (CBIO)
GlassBridge Enterprises, Inc. (GLA)
Summit State Bank (SSBI)
Global Net Lease, Inc. (GNL)
Rennova Health, Inc. (RNVA)
Hennessy Advisors, Inc. (HNNA)
Comcast Corporation (CMCSA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ATRC Insider Buying

ATRC Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.